54 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp01292 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MOLT-4 | Leukemia | IC50 : 4-5 μM |
| dbacp01293 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HOP-62 | Lung cancer | IC50 : 5 μM |
| dbacp01294 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HCT-15 | Colon cancer | IC50 : 4-5 μM |
| dbacp01295 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SF-539 | CNS cancer | IC50 : 5 μM |
| dbacp01296 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MDA-MB-435 | Melanoma | IC50 : 5 μM |
| dbacp01297 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | OVCAR-4 | Ovarian cancer | IC50 : 5 μM |
| dbacp01298 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | CAKI-1 | Renal cancer | IC50 : 5 μM |
| dbacp01299 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | Not found | Prostate cancer | IC50 : 5 μM |
| dbacp01300 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MDA-MB-468 | Breast cancer | IC50 : 5 μM |
| dbacp01329 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | K-562 | Leukemia | IC50 : 4-5 μM |
| dbacp01330 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | HOP-92 | Lung cancer | IC50 : 5 μM |
| dbacp01331 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | HCT-116 | Colon cancer | IC50 : 4-5 μM |
| dbacp01332 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | SNB-19 | CNS cancer | IC50 : 5 μM |
| dbacp01333 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | M14 | Melanoma | IC50 : 5 μM |
| dbacp01334 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | OVCAR-5 | Ovarian cancer | IC50 : 5 μM |
| dbacp01335 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | ACHN | Renal cancer | IC50 : 5 μM |
| dbacp01336 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | Not found | Prostate cancer | IC50 : 5 μM |
| dbacp01337 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Green and golden bell frog | Cell membrane disintegration | One-dose and five-dose assay | HS 578T | Breast cancer | IC50 : 5 μM |
| dbacp01347 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | RPMI-8226 | Leukemia | IC50 : 4-5 μM |
| dbacp01348 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | EKVX | Lung cancer | IC50 : 5 μM |
| dbacp01349 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HT29 | Colon cancer | IC50 : 4-5 μM |
| dbacp01350 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SF-295 | CNS cancer | IC50 : 5 μM |
| dbacp01351 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SK-MEL-2 | Melanoma | IC50 : 5 μM |
| dbacp01352 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | OVCAR-3 | Ovarian cancer | IC50 : 5 μM |
| dbacp01353 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | RXF 393 | Renal cancer | IC50 : 5 μM |
| dbacp01354 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | DU-145 | Prostate cancer | IC50 : 5 μM |
| dbacp01355 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MDA-MB-231/ATCC | Breast cancer | IC50 : 5 μM |
| dbacp01356 | Aurein-2.7 | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SR | Leukemia | IC50 : 4-5 μM |
| dbacp01358 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | CCRF-CEM | Leukemia | IC50 : 4-5 μM |
| dbacp01359 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | NCI-H23 | Lung cancer | IC50 : 5 μM |
| dbacp01360 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | COLO 205 | Colon cancer | IC50 : 4-5 μM |
| dbacp01361 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | U251 | CNS cancer | IC50 : 5 μM |
| dbacp01362 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | LOX IMVI | Melanoma | IC50 : 5 μM |
| dbacp01363 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | NCI/ADR-RES | Ovarian cancer | IC50 : 5 μM |
| dbacp01364 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | 786-0 | Renal cancer | IC50 : 5 μM |
| dbacp01365 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | Not found | Prostate cancer | IC50 : 5 μM |
| dbacp01366 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | BT-549 | Breast cancer | IC50 : 5 μM |
| dbacp01371 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HL-60(TB) | Leukemia | IC50 : 4-5 μM |
| dbacp01372 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | NCI-H226 | Lung cancer | IC50 : 5 μM |
| dbacp01373 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HCC-2998 | Colon cancer | IC50 : 4-5 μM |
| dbacp01374 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SNB-75 | CNS cancer | IC50 : 5 μM |
| dbacp01375 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MALME-3M | Melanoma | IC50 : 5 μM |
| dbacp01376 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | OVCAR-8 | Ovarian cancer | IC50 : 5 μM |
| dbacp01377 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | A498 | Renal cancer | IC50 : 5 μM |
| dbacp01378 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | Not found | Prostate cancer | IC50 : 5 μM |
| dbacp01379 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MDA-N | Breast cancer | IC50 : 5 μM |
| dbacp01384 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | A549/ATCC | Lung cancer | IC50 : 5 μM |
| dbacp01385 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | KM12 | Colon cancer | IC50 : 4 - 5 μM |
| dbacp01386 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SF-268 | CNS cancer | IC50 : 5 μM |
| dbacp01387 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SK-MEL-28 | Melanoma | IC50 : 5 μM |
| dbacp01388 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | IGR-OV1 | Ovarian cancer | IC50 : 5 μM |
| dbacp01389 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SN12C | Renal cancer | IC50 : 5 μM |
| dbacp01390 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | PC-3 | Prostate cancer | IC50 : 5 μM |
| dbacp01391 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MCF7 | Breast cancer | IC50 : 5 μM |